Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022

SELL
$7.65 - $14.24 $897,964 - $1.67 Million
-117,381 Closed
0 $0
Q1 2022

May 13, 2022

SELL
$13.02 - $20.78 $336,384 - $536,872
-25,836 Reduced 18.04%
117,381 $1.67 Million
Q4 2021

Feb 08, 2022

BUY
$19.35 - $25.54 $2.77 Million - $3.66 Million
143,217 New
143,217 $2.96 Million
Q3 2021

Nov 15, 2021

SELL
$21.65 - $39.49 $1.26 Million - $2.3 Million
-58,304 Closed
0 $0
Q2 2021

Aug 16, 2021

BUY
$15.5 - $22.48 $903,712 - $1.31 Million
58,304 New
58,304 $1.21 Million
Q4 2020

Feb 02, 2021

SELL
$9.4 - $16.7 $174,473 - $309,968
-18,561 Closed
0 $0
Q3 2020

Nov 05, 2020

SELL
$10.54 - $24.96 $1.33 Million - $3.15 Million
-126,284 Reduced 87.19%
18,561 $196,000
Q2 2020

Jul 22, 2020

BUY
$21.87 - $33.11 $1.21 Million - $1.83 Million
55,190 Added 61.56%
144,845 $3.54 Million
Q1 2020

May 06, 2020

BUY
$16.25 - $35.28 $1.46 Million - $3.16 Million
89,655 New
89,655 $2.16 Million

Others Institutions Holding ALEC

About Alector, Inc.


  • Ticker ALEC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 82,563,904
  • Market Cap $159M
  • Description
  • Alector, Inc., a clinical stage biopharmaceutical company, develops therapies for the treatment of neurodegeneration diseases. Its products include AL001, a humanized recombinant monoclonal antibody, which is in Phase III clinical trial for the treatment of frontotemporal dementia, Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis dise...
More about ALEC
Track This Portfolio

Track First Trust Advisors LP Portfolio

Follow First Trust Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Trust Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on First Trust Advisors LP with notifications on news.